Novartis (NVS)

Add to Watchlists
Create an Alert
70.65 +0.22  +0.31% NYSE Jan 20, 20:00 Delayed 2m USD

Novartis Enterprise Value:

194.48B for Jan. 20, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Novartis Enterprise Value Chart

Export Data
Save Image
Print Image

Novartis Historical Enterprise Value Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Jan. 20, 2017 194.48B
Jan. 19, 2017 193.95B
Jan. 18, 2017 197.42B
Jan. 17, 2017 197.66B
Jan. 13, 2017 198.63B
Jan. 12, 2017 199.56B
Jan. 11, 2017 199.39B
Jan. 10, 2017 202.70B
Jan. 9, 2017 202.84B
Jan. 6, 2017 201.22B
Jan. 5, 2017 202.60B
Jan. 4, 2017 199.16B
Jan. 3, 2017 199.66B
Dec. 30, 2016 199.68B
Dec. 29, 2016 198.73B
Dec. 28, 2016 196.78B
Dec. 27, 2016 197.78B
Dec. 23, 2016 197.33B
Dec. 22, 2016 197.14B
Dec. 21, 2016 196.52B
Dec. 20, 2016 197.59B
Dec. 19, 2016 196.81B
Dec. 16, 2016 197.16B
Dec. 15, 2016 195.45B
Dec. 14, 2016 195.17B
   
Dec. 13, 2016 195.83B
Dec. 12, 2016 191.60B
Dec. 9, 2016 192.32B
Dec. 8, 2016 187.21B
Dec. 7, 2016 189.65B
Dec. 6, 2016 190.46B
Dec. 5, 2016 190.49B
Dec. 2, 2016 188.59B
Dec. 1, 2016 187.59B
Nov. 30, 2016 189.99B
Nov. 29, 2016 190.46B
Nov. 28, 2016 190.75B
Nov. 25, 2016 191.94B
Nov. 23, 2016 190.11B
Nov. 22, 2016 188.40B
Nov. 21, 2016 193.24B
Nov. 18, 2016 194.45B
Nov. 17, 2016 198.97B
Nov. 16, 2016 198.14B
Nov. 15, 2016 197.45B
Nov. 14, 2016 197.78B
Nov. 11, 2016 201.22B
Nov. 10, 2016 202.60B
Nov. 9, 2016 203.12B
Nov. 8, 2016 195.97B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

NVS Enterprise Value Benchmarks

Companies
AstraZeneca 84.00B
GlaxoSmithKline 118.34B
Johnson & Johnson 297.10B

NVS Enterprise Value Range, Past 5 Years

Minimum 143.55B Mar 06 2012
Maximum 273.77B Jul 20 2015
Average 207.77B

NVS Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("NVS", "enterprise_value")
  • Last 5 data points: =YCS("NVS", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.